Maryline Legrand

607 total citations
8 papers, 470 citations indexed

About

Maryline Legrand is a scholar working on Pharmacology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Maryline Legrand has authored 8 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 3 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Maryline Legrand's work include Pharmacogenetics and Drug Metabolism (7 papers), Glutathione Transferases and Polymorphisms (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Maryline Legrand is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Glutathione Transferases and Polymorphisms (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Maryline Legrand collaborates with scholars based in France, Switzerland and Chile. Maryline Legrand's co-authors include Delphine Marez, Franck Broly, Jean‐Marc Lo‐Guidice, N. Sabbagh, Ursina Meyer, Catherine Spire, Philip M. Boone, Stéphanie Millecamps, Alain Dest�e and Alexis Brice and has published in prestigious journals such as Carcinogenesis, Movement Disorders and Human Genetics.

In The Last Decade

Maryline Legrand

7 papers receiving 450 citations

Peers

Countries citing papers authored by Maryline Legrand

Since Specialization

Citations

This map shows the geographic impact of Maryline Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryline Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryline Legrand more than expected).

Fields of papers citing papers by Maryline Legrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryline Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryline Legrand. The network helps show where Maryline Legrand may publish in the future.

Co-authorship network of co-authors of Maryline Legrand

This figure shows the co-authorship network connecting the top 25 collaborators of Maryline Legrand. A scholar is included among the top collaborators of Maryline Legrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryline Legrand. Maryline Legrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	CYP2D6 Polymorphism and Parkinson's disease susceptibility 1999 ·Movement Disorders ·(unknown), Alexis Brice, Delphine Marez, Alexandra D�rr, Maryline Legrand, Jean‐Marc Lo‐Guidice, Alain Dest�e, Yves Agid, Franck Broly	18
2	CYP2D6 Polymorphism and Parkinson's disease susceptibility 1999 ·Movement Disorders ·(unknown), Alexis Brice, Delphine Marez, Alexandra Dürr, Maryline Legrand, Jean‐Marc Lo‐Guidice, A. Destée, Yves Agid, Franck Broly	0
3	Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution 1997 ·Pharmacogenetics ·Delphine Marez, Maryline Legrand, N. Sabbagh, Jean‐Marc Lo‐Guidice, Catherine Spire, (unknown), Ursina Meyer, Franck Broly	305
4	SHORT COMMUNICATION: Influence of a mutation reducing the catalytic activity of the cytochrome P450 CYP2D6 on lung cancer susceptibility 1996 ·Carcinogenesis ·Maryline Legrand, (unknown), Delphine Marez, N. Sabbagh, Jean‐Marc Lo‐Guidice, Franck Broly	13
5	An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine 1996 ·Human Genetics ·Delphine Marez, Maryline Legrand, N. Sabbagh, Jean‐Marc Lo‐Guidice, Philip M. Boone, Franck Broly	20
6	A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency 1995 ·Human Genetics ·Franck Broly, Delphine Marez, Jean‐Marc Lo‐Guidice, N. Sabbagh, Maryline Legrand, Philip M. Boone, Ursina Meyer	21
7	A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype 1995 ·Pharmacogenetics ·Delphine Marez, N. Sabbagh, Maryline Legrand, Jean‐Marc Lo‐Guidice, Philip M. Boone, Franck Broly	33
8	An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis 1995 ·Pharmacogenetics ·Franck Broly, Delphine Marez, N. Sabbagh, Maryline Legrand, Stéphanie Millecamps, Jean‐Marc Lo‐Guidice, Philip M. Boone, (unknown)	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact